Postdoctoral Researcher, Fmri Innovation Program @ AbbVie
Senior Scientist Ii, Translational Imaging @ AbbVie
Senior Scientist Iii and Head of CNS and Immuno Imaging, Translational Science @ AbbVie
Chih-Liang Chin's Education
Duke University
(Leadership, Education, Business)
2018 - 2018
Insead
(Management, Education)
2013 - 2013
University of Pennsylvania
Doctor of Philosophy (Bioengineering)
1999 - 2004
Penn State University
Master of Science (Biomedical Engineering, Bioengineering)
1995 - 1997
Chung Yuan Christian University
Bachelors (Medical Engineering)
1989 - 1993
(Biomedical Engineering)
Chih-Liang Chin's Skills
Drug Discovery
Biomarkers
Pharmaceutical Industry
Translational Medicine
Digital Imaging
Drug Development
CRO
In Vivo
Clinical Trials
Bioengineering
Chih-Liang Chin's Summary
Chih-Liang Chin, based in South San Francisco, CA, US, is currently a Executive Director and Head of Pacific Translational Biomarkers at Merck at Merck, bringing experience from previous roles at Merck, Harvard Medical School and Abbvie. Chih-Liang Chin holds a 2018 - 2018 Duke University. With a robust skill set that includes Drug Discovery, Biomarkers, Pharmaceutical Industry, Translational Medicine, Digital Imaging and more, Chih-Liang Chin contributes valuable insights to the industry. Chih-Liang Chin has 2 emails and 1 mobile phone number on RocketReach.